Conirex
Natural health product licensed in Canada
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80044402
- Status
- Inactive licence
- Licence date
- 26 August 2013
- Revision date
- 18 May 2022
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide 2-aminoéthanesulfonique | 125 mg | Not calculated |
| Phosphatidylserine | 25 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Cellulose microcristalline, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 4 Capsule | minimum: 1 day ; maximum: 2 days |
Uses authorised in Canada
Provides antioxidants for the maintenance of good health. Helps to promote healthy glucose metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Consult a health care practitioner prior to use if you are pregnant or breast feeding. Consult a health care practitioner prior to use if you have liver or kidney disease or if you have been instructed to follow a low protein diet. Consult a health care practitioner prior to use if you have diabetes.
- Précautions et mises en garde
Keep out of the reach of children. Do not use if you have primary systemic L-carnitine deficiency or secondary L-carnitine deficiency (inborn errors of metabolism) for which supplementation is prescribed/monitored by a health care practitioner. Feelings of over stimulation and/or sleeplessness may occur; discontinue use if feelings persist or worsen.
Source
Official Health Canada record, licence 80044402
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.